35^th World Congress on Cardiology & Heart Diseases March 22-23, 2023 London, UK

Dr. Elio Caruso is a Pediatric Cardiologist working at Mediterranean Pediatric Heart Center, Taormina, Italy. He is an Executive Board member and Associate Editor of the Echocardiography Journal Section Pediatric Cardiology. Dr. Elio Caruso is an Editorial board member of the Congenital Heart Disease Journal and a Consultant follow-up Congenital Heart Disease patient. He received his Ph.D. from Stanford University, California.

Pediatric Cardiology, Ped Echocardiographist, and Pediatric Arrhythmias.

Dr. Lucas moved to the University of Florida in 2006_ from the Robarts Research Institute and the University of Western Ontario in London, Ontario, Canada, where she has been a principal investigator studying inflammation, specifically monocyte and T lymphocyte activation in vascular disease. Dr. Lucas is also a co-inventor and co-founding scientist for Viron Therapeutics, Inc., a biotechnology company that is now in clinical trials analyzing viral anti-inflammatory proteins as a new class of therapeutic agents. Dr. Lucas is a practicing interventional cardiologist in addition to running an active basic research lab in vascular inflammatory research with bovver 100 papers and reviews and 16 patents published. She has been an active member of the Canadian Society for Atherosclerosis and Thrombosis Board having also served as Editor-in-Chief and serving on the American Heart Association grant panel. She is additionally on the editorial board for several journals. Dr. Lucas also directs an annual medical mission to Fte. Liberte in Haiti.

Ion channels, Functional Genomics and Proteomics, Phenomics, Cardiac Electrophysiology and Pharmacology, Cardiac Ischemia, Cardioprotection, Myocardial Hypertrophy and Heart Failure.

Days Darrel Duan, MD (Hunan Medical University, 1982), MSc (Sun Yat-Sen University of Medical Sciences, 1987), Ph.D. (McGill University, 1996), is a Professor of Pharmacology and Director of the Laboratory of Cardiovascular Phonomics in the Center of Biomedical Research Excellence and the Department of Pharmacology, University of Nevada, Reno, USA. He is also a Visiting Professor at several prestigious universities in China, including Central South University XiangYa Medical College, Sun Yat-sen University, the Second Military Medical University, the Forth Military Medical University, and Harbin Medical University. He has been studying cellular and molecular electrophysiology and cardiovascular pharmacology for 25 years. He discovered several anion channels in the heart and has made significant contributions to the study of biophysics, physiology, pharmacology, and molecular biology of ion channels in the cardiovascular system. His current research, supported by NIH, American Heart Association, and American Diabetes Association, is focusing on the functional genomics, proteomics, and phenomics of ion channels in the cardiovascular systems. He has published more than 50 papers and book chapters. His publications often appear in the most prestigious journals including Nature, Physiological Review, Circulation, Circulation Research, Journal of Biological Chemistry, Journal of General Physiology, Journal of Physiology, etc. He served on the Research Committee of the Western States Affiliate of the American Heart Association. He is currently a member of the Editorial Board of Acta Pharmacologica Sinica, Proceedings of Western Pharmacological Society, and World Journal of Cardiology, and a frequent referee for more than 40 professional journals

Ion channels, Functional Genomics and Proteomics, Phenomics, Cardiac Electrophysiology and Pharmacology, Cardiac Ischemia, Cardioprotection, Myocardial Hypertrophy and Heart Failure.

Dr. Dayue Darrel Duan, MD, Ph.D., FAHA, is a Professor of Pharmacology in the Department of Pharmacology and Principle Investigator of the Laboratory of Cardiovascular Phenomics in the Center for Molecular Medicine at School of Medicine, the University of Nevada in Reno, Nevada, USA. Dr. Duan discovered several anion channels in the heart and has made significant original contributions to the study of biophysics, physiology, pharmacology, and molecular biology of ion channels in the cardiovascular system. His current research is focusing on the phenomics, functional genomics, and proteomics of ion channels in the cardiovascular systems. The Duan laboratory has established several animal models for cardiac diseases and hypertension and has the capacity to study the genome-phenome relationship and molecular mechanisms for cardiovascular disease at multiple levels ranging from the whole animal to molecular levels. He delivered over 200 invited lectures and seminars throughout the world and has published more than 80 peer-reviewed papers and book chapters.

Ion channels, Functional Genomics and Proteomics, Phenomics, Cardiac Electrophysiology and Pharmacology, Cardiac Ischemia, Cardioprotection, Myocardial Hypertrophy and Heart Failure.

Roxana Mehran, MD, is a Professor of Medicine at Mount Sinai School of Medicine, Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute, and Chief Scientific Officer of the Clinical Trial Center at the Cardiovascular Research Foundation. She was previously an Associate Professor of Medicine and Director of Outcomes Research, Data Coordination, and Analysis at the Center for Interventional Vascular Therapy, Columbia University Medical Center. Dr. Mehran is internationally recognized for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiology. She is also recognized for her experience and expertise in working with regulatory agencies to conduct clinical trials. Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients, as well as advancing treatments for acute coronary syndromes and acute myocardial infarction. In addition to founding a highly regarded academic research organization (ARO) within the Cardiovascular Research Foundation, she is also a widely published author in the most respected cardiovascular journals, and has authored and co-authored and co-edited a significant number of books and book chapters. Dr. Mehran has been an invited speaker at national and international scientific conferences such as the American Heart Association, American College of Cardiology, European Society of Cardiology, and EuroPCR, and has served as Course Co-Director of the annual Transcatheter Cardiovascular Therapeutics (TCT) for the last 13 years. Dr. Mehran completed her training in internal medicine at the University of Connecticut, where she was Chief Medical Resident, before continuing her studies in Cardiovascular Diseases and Interventional Cardiology at Mount Sinai Medical Center in New York. She is an elected fellow of the American College of Cardiology, American College of Physicians, American Heart Association, Society of Cardiac Angiography and Intervention (SCAI), and the European Society of Cardiology. She currently serves on the board of trustees of SCAI, as a member of the Program Committee for the American Heart Association Scientific Sessions, and as Program Chair for SCAIs WIN (Women In Innovations) Initiative.

Acute Coronary Syndrome; cardiac-catheterization; Coronary Artery Disease; Coronary Stenting; High Blood Pressure; High Cholesterol; Hyperlipidemia